🇺🇸 FDA
Patent

US 8148560

Vaginal tablets comprising misoprostol and methods of making and using the same

granted A61KA61K31/5575A61K31/57

Quick answer

US patent 8148560 (Vaginal tablets comprising misoprostol and methods of making and using the same) held by TEVA WOMEN'S HEALTH, INC. expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA WOMEN'S HEALTH, INC.
Grant date
Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/5575, A61K31/57, A61K9/0034, A61K9/2018